|
51 |
Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells
Enthalten in Breast cancer research Bd. 11, 10.8.2009, Nr. 4, date:8.2009: 1-9
|
|
|
|
52 |
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Enthalten in Breast cancer research Bd. 9, 26.10.2007, Nr. 5, date:10.2007: 1-8
|
|
|
|
53 |
ERalpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients
Enthalten in Breast cancer research Bd. 10, 15.9.2008, Nr. 5, date:10.2008: 1-8
|
|
|
|
54 |
Evaluation of sonographic detectability of different markers within an in vitro simulation model of the axilla
Enthalten in Archives of gynecology and obstetrics Bd. 304, 17.6.2021, Nr. 3, date:9.2021: 839-848
|
|
|
|
55 |
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
Enthalten in Breast cancer research Bd. 14, 20.1.2012, Nr. 1, date:2.2012: 1-9
|
|
|
|
56 |
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Enthalten in BMC cancer Bd. 11, 28.1.2011, Nr. 1, date:12.2011: 1-10
|
|
|
|
57 |
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
Enthalten in BMC cancer Bd. 20, 11.11.2020, Nr. 1, date:12.2020: 1-13
|
|
|
|
58 |
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study
Enthalten in BMC cancer Bd. 19, 21.6.2019, Nr. 1, date:12.2019: 1-9
|
|
|
|
59 |
LEFTY2 inhibits endometrial receptivity by downregulating Orai1 expression and store-operated Ca2+ entry
Enthalten in Journal of molecular medicine Bd. 96, 11.12.2017, Nr. 2, date:2.2018: 173-182
|
|
|
|
60 |
Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer
Enthalten in BMC cancer Bd. 13, 5.7.2013, Nr. 1, date:12.2013: 1-8
|
|
Administration
